Index trend and stocks in action March 23, 2018
Index trend and stocks in action March 23, 2018

Index trend and stocks in action March 23, 2018

Karan Dsij Article rating: 5.0

The level of 10,040-10,000 will be crucial for the Nifty as a decisive move below this level would trigger further sell-off, which may take Nifty towards the level of 9,930. 

Overnight Digest: Stocks to look out for on March 23
Overnight Digest: Stocks to look out for on March 23

Overnight Digest: Stocks to look out for on March 23

Nikita Singh Article rating: 5.0

The stocks that are likely to witness significant movement on the bourses on Friday, March 23, 2018 are L&T Technology Services Limited, Dilip Buildcon Limited, JSW Energy Limited, Infosys Limited and Alankit Limited.     

How Fed rate hike will impact India?
How Fed rate hike will impact India?

How Fed rate hike will impact India?

Shashikant Singh Article rating: 3.7

US Federal Reserve hikes interest rate for the fourth time in a year, let's discuss how is it going to impact Indian economy.

SME IPO: SS Infrastructure to launch IPO on March 28
SME IPO: SS Infrastructure to launch IPO on March 28

SME IPO: SS Infrastructure to launch IPO on March 28

Nikita Singh Article rating: 4.7

Engineering and architectural consultancy SS Infrastructure Development Consultants is buckling up to launch its initial public offering on the EMERGE platform of National Stock Exchange of India on March 28, 2018.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 5.0

The markets on March 22, 2018 opened flat. BSE Sensex is trading at 33,116.86, down by 19.32 points and the Nifty is trading at 10,150.75, down by 4.50 points.

Suven Life Sciences secures product patents in Norway, S Korea and Singapore
Suven Life Sciences secures product patents in Norway, S Korea and Singapore

Suven Life Sciences secures product patents in Norway, S Korea and Singapore

Nidhi Jani Article rating: 5.0

Suven Life Sciences secured product patents from Norway, South Korea and Singapore regulators corresponding to the New Chemical Entities (NCEs) for the treatment of disorders allied with Neurodegenerative diseases.

RSS
First30303031303230333035303730383039Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR